Reach Us +44-1904-929220
Current Research: Cardiology

Sign up for email alert when new content gets added: Sign up

*Corresponding Author:
Dr AA Akintunde
PO Box 3238, Osogbo, Osun State, Nigeria.
Telephone: 234-803-393-2076
E-mail: [email protected], [email protected]

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (, which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact [email protected]


Background: Fragmented QRS (fQRS), QT prolongation and wide QRS have been associated with increased risk for cardiac arrhythmias. Objectives : To describe the prevalence and correlates among Nigerians with heart failure.

Methods: A total of 129 subjects were consecutively recruited for the present study. QT interval, QRS duration and fQRS were determined. SPSS version 16 was used for analysis.

Results: The mean (± SD) age was 62.1±13.7 years (43.4% female). Mean QT, QTc and QRS durations were 390.4±56.2 ms, 451.3±62.7 ms and 99.5±23.9 ms, respectively. fQRS, QTc prolongation and wide QRS occurred in 41.1%, 44.2% and 41.9%, respectively, of study participants. fQRS appeared to be more likely associated with prolonged QTc, increased heart rate, presence of old myocardial infarction and wide QRS duration among study participants.

Conclusion: fQRS, QTc prolongation and wide QRS are frequent among Nigerians with heart failure. Appropriate screening for heart failure is suggested for early intervention.


Clinical correlates; Electrocardiographic abnormalities; Fragmented QRS; Heart failure; Prevalence

Fragmented QRS (fQRS), an easily evaluated noninvasive electrocardiographic parameter, is an important marker of myocardial injury [1]. It is defined as additional spikes within the QRS complex; or the presence of an additional R wave (R′); or notching in the nadir of the S wave; or the presence of >1 R′ in two contiguous leads corresponding to a major coronary artery territory on the resting 12-lead electrocardiogram (ECG) (Figure 1). fQRS has been associated with, and is also a predictor of, mortality and arrhythmic events in patients with reduced left ventricular systolic function among Caucasians [2,3]. Although fQRS was initially used as a marker of myocardial scar in coronary artery disease, its usefulness has been expanded to other diseases such as cardiac sarcoidosis, arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy, Brugada syndrome and acquired long QT syndrome [4,5]. fQRS complex has also been proposed as an additional tool to separate individuals with left ventricular diastolic dysfunction from those with heart failure with preserved ejection fraction [6].


Figure 1: Example of fragmented QRS pattern

In a review of 50 cases of sudden death from Ile-Ife (southwestern Nigeria), death was attributed to acute left ventricular failure in 68% of the subjects, while only 4% of deaths were attributed to acute myocardial infarction [7]. In a recent nine-year review of cases of sudden death from Osogbo, Nigeria, cardiovascular disease, especially heart failure, was the most common cause of sudden death [8]. In another review of autopsied cases in southern Nigeria over a nine-year period, cardiovascular disease was the most common cause of sudden death, accounting for 87.6% of all-cause mortality [9].

Sudden cardiac death is the most common cause of mortality in heart failure subjects [6], which is often related to malignant supraventricular and ventricular arrhythmias [10]. Conventional markers, such as left ventricular ejection fraction, have been widely used to predict mortality [10,11]. The initiation and maintenance of re-entrant ventricular arrhythmias depends on the triggers and a vulnerable myocardial substrate [12]. Depolarization and repolarization abnormalities including fQRS, microwave T wave alternans, QT prolongation, QT dispersion and wide QRS have been shown to predict sudden cardiac death in many populations [1,8,12]. Das and Masry [12] demonstrated that the fQRS represents conduction delay due to myocardial scar in patients with coronary artery disease, and that it is also similar for other myocardial diseases. fQRS are, therefore, potential substrates for initiation of cardiac arrhythmias in patients with heart failure. While this has been studied among the Caucasian population, reports of fQRS and other depolarization abnormalities are rare among Nigerians.

Accordingly, we aimed to determine the frequency of fQRS and QT prolongation among a group of Nigerian subjects with heart failure, and describe the clinical and demographic characteristics as well as associated clinical correlates.

Materials and Methods

The study was performed in the Goshen Heart Clinic, Osogbo, Nigeria. The clinical records of all heart failure cases seen between May 2011 and December 2014 were retrieved. All potential subjects were included if they were >18 years of age. Subjects with serious comorbidities including cancers, advanced kidney disease and stroke were excluded. Subjects with metabolic abnormalities, such as hyperkalemia, those taking tricyclic antidepressants, early repolarization abnormalities and history suggestive of pulmonary embolism, were also excluded from the analysis. Information obtained from the clinical records included age, sex, occupation, clinical features of heart failure, drug history, history of hypertension and diabetes mellitus, smoking history, alcohol history and duration of symptoms. Height, weight, waist circumference, average systolic and diastolic blood pressure, and heart rate were obtained. Electrocardiography was performed using the ECG 1200 (Contec Medical Systems, China). Echocardiography was performed using the HP Sonos 2500 (HP Inc, USA) with a 2.7/3.5 MHz probe. Echocardiography was performed according to standardized American Society of Echocardiography guidelines on quantification and evaluation of systolic and diastolic parameters and chambers assessment [13]. The following parameters were obtained: left ventricular internal dimension in diastole, left ventricular internal dimension in systole, left ventricular posterior and septal wall dimension in diastole, ejection fraction, fractional shortening, left atrial dimension, right ventricular wall dimension and aortic root dimension. Global and regional assessment for wall motion abnormalities were made visually and reported. The electrocardiography was interpreted by the author blinded to the clinical data of the subjects. Parameters such as heart rate, rhythm, QRS axis, PR interval and QTc were obtained. Left ventricular hypertrophy was defined using the Sokolow-Lyon criteria [11,13]. Fasting blood sugar, lipid profile including high-density lipoprotein cholesterol, lowdensity lipoprotein cholesterol, total cholesterol and triglycerides were obtained using a rapid point-of-care, strip-based test (LipidPro; Infopia Ltd, Korea).

fQRS was defined on the 12-lead ECG including various morphologies of the QRS wave with or without a Q wave. fQRS include the presence of an additional R wave (R′) or notching in the nadir of the R wave or the S wave, or the presence of >1 R′ (fragmentation) in two contiguous leads corresponding to a major coronary artery territory. In the presence of left or right bundle branch block or premature ventricular complexes, fQRS was defined as the presence of >2 notches in the R or S wave [1,2,10].

QT intervals including the QT duration and QTc duration were calculated using ECG Synchronous V1.3.3 computer software (Contec Medical Systems, China). Prolonged QTc was defined as QTc >460 ms in women and >440 ms in men. Wide QRS was defined as QRS duration >100 ms (6,12). Data were analyzed using SPSS version 16.0 (IBM Corporation, USA). Numerical data were summarized as mean ± SD. Qualitative data were summarized as frequency and percentages. Student’s t test and the λ2 test were used as appropriate to determine differences between groups; P<0.05 was considered to be statistically significant.


Table 1 shows the clinical characteristics of heart failure subjects. The mean age was 62.1±13.7 years. There were 56 (43.4%) women in the study group. The mean systolic and diastolic blood pressures were 136.6±28.6 mmHg and 83.2±17.6 mmHg, respectively, while the mean fasting blood sugar was 4.7±2.2 mmol/L. The mean ejection fraction was 56.2±12.4%. fQRS was documented in 53 (41.1%) of heart failure patients. QTc prolongation and wide QRS were found in 57 (44.2%) and 54 (41.9%), respectively. The mean heart rate was 79.5±19.6 beats/min while the mean QRS duration was 99.5±23.9 ms. Mean QTc duration was 451.3±62.7 ms. Relative wall abnormalities seen on echocardiography was demonstrated among eight (6.2%) study participants. ST-T wave abnormalities were more common, and were evident in 68 (52.7%) of heart failure subjects in the present study. Pathological Q wave was found in 13 (10.1%) of study participants while evidence of old myocardial infarction was found in 18 (13.95%). Most patients had left atrial dilation. The mean left atrial dimension was 45.9±9.2 mm.

Variable Results
Age, years 62.1±13.7
Female sex, n (%) 56 (43.4)
Systolic blood pressure, mmHg 136.6±28.6
Diastolic blood pressure, mmHg 83.2±17.6
Fasting blood sugar, mmol/L 4.7±2.2
Left ventricular internal dimension in diastole, mm 49.0±11.9
Left ventricular end-systolic dimension, mm 37.3±12.7
Posterior wall thickness in diastole, mm 12.6±1.9
Interventricular septal thickness, mm 12.7±2.4
Mean mitral E/A ratio 1.1±0.8
Mean tricuspid E/A ratio 1.1±0.7
Ejection fraction, % 56.2±12.4
Right ventricular dimension, mm 29.5±5.4
Left atrial dimension, mm 45.9±9.2
Relative wall motion abnormalities, n (%) 8(6.2)
ST-T wave abnormalities, n (%) 68(52.7)
Pathological Q wave in contiguous leads, n (%) 13(10.1)
Proportion of those with possible silent old coronary 18/129(13.95)
artery disease, n/n (%)
Prevalence of fragmented QRS, n (%) 53(41.1)
QT duration, ms 390.4±56.2
QTc prolongation, n (%) 57(44.18)
Wide QRS (>100 ms), n (%) 54(41.9)
Heart rate, beats/min 79.5±19.6
QRS duration, ms 99.5±23.9
QTc duration, ms 451.3±62.7
New York Heart Association III/IV, n (%) 41(31.7)
Heart failure with preserved ejection fraction, n (%) 67(51.9)

Table 1: The clinical characteristics of heart failure subjects.

The clinical, demographic and electrocardiographic differences between those with fQRS and those without fQRS are shown in Table 2. Those with fQRS were more likely to have a significantly higher heart rate compared with those without fQRS (87.2±18.3 beats/min versus 80.4±17.3 beats/min; P<0.05). Although mean QRS duration and mean QTc duration were higher among those with fQRS, the differences were not statistically significant. However, the proportion of those with prolonged QTc, old myocardial infarction and wide QRS duration were significantly higher among those with fQRS compared with those without fQRS in the present study population. Mean ejection fraction was significantly lower among subjects with fQRS compared with those without (46.1±11.0% versus 58.3±12.7%; P<0.05).

Variable Present Absent P
Heart rate, beats/min 87.2 ± 18.3 80.4 ± 17.3 0.047*
QRS duration, ms 100.2 ± 25.0 96.6 ± 22.0 0.520
QT duration, ms 391.4 ± 58.5 389.0 ± 48.6 0.979
QTc, ms 463.9 ± 70.3 448.3 ± 46.3 0.698
Age, years 60.8 ± 15.8 62.2 ± 12.2 0.894
Female sex, n (%) 20 (15.5) 37 (28.7) 0.610
Prolonged QTc, n 32 21 0.000*
Old myocardial infarction, n 11 7 0.002*
Wide QRS, n 39 13 0.000*
Ejection fraction, % 46.1 ± 11.0 58.3 ± 12.4 0.035*

Table 2: Clinical and electrocardiographic differences between those with and without fragmented QRS (fQRS) on 12-lead electrocardiogram.


Heart failure is fast becoming a major cause of increasing morbidity and mortality in Africa. This is due to the increasing prevalence of its many associated risk factors including hypertension, diabetes, etc; availability of newer drugs; and the influence of technology in management such as availability of pacemakers, implantable cardioverter defibrillators, etc. In heart failure, the prognosis has been likened to that of a malignancy. The most common cause of death in heart failure is due to sudden cardiac death, which is linked to arrhythmias [6,8-9]. It is pertinent to identify potential markers of susceptibility to increased cardiac death among Africans [1,3]. fQRS has been shown to be a major marker of myocardial scar/injury in coronary artery disease and many other diseases with high sensitivity and specificity [14].

The present study revealed that fQRS is common among Nigerians with heart failure because it occurred in 41.4% of study participants. This is similar to reports from other parts of the world. In a study by Rad et al [15], 41.5% of heart failure patients in Iran were reported to have fQRS. In that study, they also showed that fQRS is a sign of myocardial scar and predicts nonresponsiveness to cardiac resynchronization therapy in heart failure, a recent technologically derived, device-based therapy useful in biventricular noncompaction and impaired synchronization and advanced heart failure. The presence of fQRS has been shown to be associated with a significantly higher all-cause mortality even after adjusting for other conventional risk markers such as ejection fraction, age, history of diabetes mellitus, etc [16]. This was also compatible with our findings in the present study, in which subjects with fQRS were more likely to have increased heart rate, lower ejection fraction and other depolarization abnormalities compared with those without fQRS. In other reports from other developing countries such as India and China, fQRS was reported in 23% to 75% of patients with dilated cardiomyopathy and heart failure, and it was associated with interventricular dysynchrony [16,17].

The present study also revealed that a significant proportion of heart failure patients had prolonged QTc and wide QRS (QRS duration >100 ms) and that they were closely linked to the presence of fQRS and other potential markers of increased mortality such as increased age and the association with the presence of ECG changes suggestive of old myocardial infarction. This is also similar to other reports from around the world. Kashani and Barold [18] reported that prolonged QRS (QRS duration >120 ms) occurs in 14% to 47% of patients with heart failure. QRS prolongation and wide QRS have been shown to be significant predictors of left ventricular systolic dysfunction in patients with heart failure and are, consequently, predictors of poor prognosis in heart failure [18,19]. Heart failure patients with QRS prolongation and wide QRS have higher all-cause mortality and, possibly, a higher incidence of sudden death, and this increases as the QRS duration increases [20].

QT and QTc prolongation is also associated with increased risk for cardiovascular death [6,19]. The QT interval is a measure of the duration of ventricular depolarization and repolarization, and is a method of screening for those at increased risk of cardiac arrhythmias [21]. QTc prolongation is also associated with various components of the insulin resistance syndrome, age, body mass index, left ventricular hypertrophy and resistant hypertension [22]. A significant proportion of study participants also had QTc prolongation and this was more frequent among women than men. Prolonged QTc was also associated with the presence of fQRS among the study participants. This is similar to what was reported in other studies from other part of the world. Sandhu and Bahler [19] reported QTc prolongation in 43% of heart failure patients undergoing surgical revascularization and also concluded that patients with heart failure and preoperative QTc interval prolongation have increased mortality rates after coronary artery bypass grafting.

The proportion of QTc prolongation found in this study is, however, less than what was described by Kolo et al [23,24] from North Central Nigeria among chronic heart failure patients; in that study, 63% of subjects had QTc prolongation. We suggest that those patients possibly had a more advanced heart failure as evidenced by their mean ejection fraction, which was significantly lower than that in our study. Arrhythmias are not uncommon in Nigerians with heart failure; 24 h ambulatory ECG monitoring has shown that ambulant outpatients with chronic heart failure have significantly higher prevalence of ventricular arrhythmias and narrow heart rate variability compared with healthy individuals of comparable age and sex [23]. Kolo et al [23,24] also showed that QTc is an important predictor of mortality in subjects with chronic heart failure in Nigeria. The presence of fQRS represents distortion of signal conduction and depolarization process within the ventricles and is related to myocardial scar/ischemia/fibrosis. It is not surprising that fQRS is related to QT prolongation and QRS duration >100 ms in the present study, which are widely acceptable conventional markers of increased cardiac susceptibility to cardiac arrhythmias and cardiovascular death in the general population and, specifically, in heart failure patients [9,10,18,20]. Although there is controversial evidence on its specificity as a screening tool for proarrhythmias, it still has significant prognostic and economic value in many cardiac and noncardiac diseases. Other causes of QT prolongation include medications such as beta-blockers, digoxin, etc, which most of our heart failure patients were using. Other causes of QT abnormalities including congenital long QT syndrome. Treatments for these abnormalities are multidimensional, and includes appropriate evaluation and monitoring, the withdrawal of offensive medications, use of implantable cardioverter defibrillators, surgical revascularization and correction of electrolyte imbalance, etc.


fQRS, QTc prolongation and wide QRS duration frequently occur among Nigerians with heart failure and may be potential predictors of increased cardiovascular susceptibility to cardiac arrhythmias and sudden cardiac death among heart failure patients. Monitoring is, therefore, essential. Appropriate interventions including withdrawal of some medications, use of devices such as implantable cardioverter defibrillators, among others, after appropriate criteria have been met, are necessary to reduce the increased risk of cardiac death among these patients. We therefore suggest routine measurement of QT parameters and identifying fQRS to properly identify, follow up and manage heart failure subjects with high cardiovascular risk.


The authors have no financial disclosures or conflicts of interest to declare.